Skip to main content
main-content
Top

17-12-2020 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: What do we know?

Speaker: Jinoos Yazdany

In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19. 

For the introductory podcast, Jinoos Yazdany, rheumatologist and Professor of Medicine at the University of California, San Francisco in the USA, talks about the rationale behind investigating these agents and the role of rheumatologists in ensuring they are studied as safely and efficiently as possible.

Listen below or subscribe to this Podcast on:

Google PodcastsApple Podcasts | SpotifyStitcher | TuneIn

About the speaker

Jinoos Yazdany

Jinoos Yazdany is Chief of the Division of Rheumatology at San Francisco General Hospital and the Alice Betts Endowed Professor of Medicine at The University of California, San Francisco, USA.


Full biography

Related topics

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

  • » Featuring insights from the COVID-19 Global Rheumatology Alliance, EULAR, and the Lupus Foundation of America
Image Credits